Publication | Open Access
Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer
86
Citations
25
References
2018
Year
Our findings implicate CD177 as a biomarker for bevacizumab and suggest VEGF/Ang2 inhibition as a strategy to overcome neutrophil associated resistance to anti-angiogenic treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1